Osaic Holdings
OLMA icon

Osaic Holdings’s Olema Pharmaceuticals OLMA Stock Holding History

Osaic Holdings’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.73K Sell
317
-157
-33% -$3.5K ﹤0.01% 6711
2025
Q4 		$11.8K Buy
+474
New +$8.43K ﹤0.01% 6230
2025
Q3 		– Sell
-5
Closed -$21 – 7971
2025
Q2 		$21 Buy
+5
New +$22 ﹤0.01% 7658
2025
Q1 		– Sell
-385
Closed -$2.25K – 7646
2024
Q4 		$2.25K Sell
385
-558
-59% -$5.57K ﹤0.01% 6567
2024
Q3 		$11.3K Buy
943
+238
+34% +$3.04K ﹤0.01% 5746
2024
Q2 		$7.63K Buy
705
+355
+101% +$3.85K ﹤0.01% 5951
2024
Q1 		$3.96K Buy
+350
New +$4.52K ﹤0.01% 6198
2023
Q4 		– Sell
-1
Closed -$12 – 7416
2023
Q3 		$12 Buy
+1
New +$10 ﹤0.01% 7332

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Osaic Holdings's OLMA Position: Q1 2026 in Review

Osaic Holdings reduced its Olema Pharmaceuticals (OLMA) stake by 33% in Q1 2026, selling an estimated $3.5K and leaving 317 shares worth $4.73K. The position accounts for ﹤0.01% of the portfolio, ranked #6711.

Osaic Holdings first reported a position in OLMA in Q3 2023 and has held it in 8 quarters since. The position peaked at $11.8K in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Osaic Holdings held 317 shares of Olema Pharmaceuticals worth $4.73K as of Q1 2026.
  • Osaic Holdings sold 157 Olema Pharmaceuticals shares in Q1 2026, an estimated $3.5K.
  • Olema Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6711 holding.
  • Osaic Holdings first reported a position in Olema Pharmaceuticals in Q3 2023 and has held it in 8 quarters since.
  • Osaic Holdings's Olema Pharmaceuticals position peaked at $11.8K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.